05/17/2024
5:11 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:15 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:18 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2024
5:27 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2024
5:21 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
5:29 PM | Day One Biopharmaceuticals (Subject)
York Charles N II (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
5:34 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
05/16/2024
5:43 PM | Day One Biopharmaceuticals (Subject)
Dubow Adam (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/14/2024
5:13 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
3:35 PM | Day One Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
3:30 PM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
5:44 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
5:48 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
7:01 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2024
5:36 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2024
5:09 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:24 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
6:55 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:48 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:36 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:14 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
5:26 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
4:51 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
7:50 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Day One Biopharmaceuticals (Subject)
| Form SC 13G | |
01/19/2024
4:19 PM | Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:22 PM | Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/19/2024
4:01 PM | Dable Habib J (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/19/2024
4:09 PM | Day One Biopharmaceuticals (Issuer)
Grossman William (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/17/2024
7:25 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
6:25 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:29 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:17 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/09/2024
6:22 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
7:30 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
3:06 PM | Day One Biopharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/17/2023
5:20 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:26 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:30 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:33 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
6:07 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Urgent Nvidia Warning (Ad) Could Steve Job's 'Final Prophecy' Make You Rich?
Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space. Click here to access… |
11/16/2023
7:39 PM | Day One Biopharmaceuticals (Issuer)
Dubow Adam (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/16/2023
5:08 PM | Day One Biopharmaceuticals (Subject)
Dubow Adam (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/16/2023
5:24 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2023
3:48 PM | Day One Biopharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
3:30 PM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
7:12 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
3:02 PM | Access Industries Holdings LLC (Reporting)
ACCESS INDUSTRIES MANAGEMENT, LLC (Reporting)
AI Day1 LLC (Reporting)
Blavatnik Len (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
4:28 PM | Day One Biopharmaceuticals (Filer)
| Form S-3ASR | |
09/11/2023
7:35 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
6:02 PM | Day One Biopharmaceuticals (Issuer)
York Charles N II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
5:21 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
5:16 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
7:06 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:19 AM | Day One Biopharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
07/05/2023
6:47 PM | Bender Jeremy (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:44 PM | Day One Biopharmaceuticals (Issuer)
Nicholson Garry A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:47 PM | Day One Biopharmaceuticals (Issuer)
Ramasastry Saira (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:35 PM | Day One Biopharmaceuticals (Issuer)
Holles Natalie C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:39 PM | Day One Biopharmaceuticals (Issuer)
Josey John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:24 PM | Day One Biopharmaceuticals (Issuer)
Gladstone Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:15 PM | Becker Daniel J. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
6:19 PM | Day One Biopharmaceuticals (Issuer)
Garland J. Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:06 PM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/12/2023
7:07 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/07/2023
3:51 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2023
3:57 PM | Day One Biopharmaceuticals (Filer)
| Form 424B5 | |
06/07/2023
4:00 PM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
3:49 PM | Blackman Samuel C. (Reporting)
Day One Biopharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023
5:08 AM | Day One Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
